ASSESSMENT OF LIVER ENZYMES FOR THE DIAGNOSIS OF MICROCYSTIN INDUCED HEPATOTOXICITY IN THE SETTING OF PRE-EXISTING LIVER DISEASE

被引：0
|
作者：
Su, Robin [1 ]
Lad, Apurva [1 ]
Kleinhenz, Andrew [1 ]
Haller, Steven T. [1 ]
Kennedy, David J. [1 ]
机构：
[1] Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2019年 / 67卷 / 05期
关键词：
D O I：
10.1136/jim-2019-midwestern2019.52
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A29
引用
收藏
页码：895 / 895
页数：1
相关论文
共 50 条
  • [41] Sirolimus-based immunosuppression for liver transplantation with pre-existing malignancy
    Kneteman, N
    Meeberg, G
    Bonar, S
    Bain, V
    Ma, M
    Issa, S
    Babini, R
    TRANSPLANTATION, 1999, 67 (07) : S201 - S201
  • [42] CLINICAL CHARACTERISTICS AND OUTCOMES OF COVID-19 PATIENTS WITH AND WITHOUT PRE-EXISTING CHRONIC LIVER DISEASE
    Krishnan, Arunkumar
    Prichett, Laura
    Tao, Xueting
    Kim, Ahyoung
    Strauss, Alexandra T.
    Hamilton, James P.
    Potter, James J.
    Alqahtani, Saleh
    Woreta, Tinsay A.
    Chen, Po-Hung
    HEPATOLOGY, 2020, 72 : 262A - 262A
  • [43] SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted
    Verma, Henu Kumar
    Bhaskar, L. V. K. S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (45) : 7855 - 7858
  • [44] Predictors of clinical outcomes of hospitalized patients with Covid-19: focusing on pre-existing liver disease
    Ferreira, Ana Isabel
    Sarmento, Maria Helena
    Cotter, Jorge
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (08) : 2209 - 2217
  • [45] Predictors of clinical outcomes of hospitalized patients with Covid-19: focusing on pre-existing liver disease
    Ana Isabel Ferreira
    Maria Helena Sarmento
    Jorge Cotter
    Internal and Emergency Medicine, 2022, 17 : 2209 - 2217
  • [46] CHARACTERIZING AL AND TTR CARDIAC AMYLOIDOSIS IN THE SETTING OF PRE-EXISTING HEART DISEASE
    Gurumoorthi, Manasa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 3111 - 3111
  • [47] SARS-CoV-2 infection in people with pre-existing liver disease:Further research is warranted
    Henu Kumar Verma
    LVKS Bhaskar
    World Journal of Gastroenterology, 2021, (45) : 7855 - 7858
  • [48] Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
    Ferron, Pierre-Jean
    Gicquel, Thomas
    Megarbane, Bruno
    Clement, Bruno
    Fromenty, Bernard
    BIOCHIMIE, 2020, 179 : 266 - 274
  • [49] Immunohistochemical localization of microcystin-LR in the liver of mice: A study on the pathogenesis of microcystin-LR-induced hepatotoxicity
    Yoshida, T
    Makita, Y
    Tsutsumi, T
    Nagata, S
    Tashiro, F
    Yoshida, F
    Sekijima, M
    Tamura, S
    Harada, T
    Maita, K
    Ueno, Y
    TOXICOLOGIC PATHOLOGY, 1998, 26 (03) : 411 - 418
  • [50] Good outcome of liver transplantation in patients with pre-existing renal cell carcinoma
    Lassailly, G.
    Ningarhari, M.
    Dumortier, J.
    Lafforgue, C.
    Bouye, S.
    Amrani, M. . El
    Lebuffe, G.
    Villers, A.
    Truant, S.
    Mathurin, P.
    Louvet, A.
    Boillot, O.
    Boleslawski, E.
    Dharancy, S.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (01)
12345